Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: Brain Res Bull. 2021 Apr 28;172:129–138. doi: 10.1016/j.brainresbull.2021.04.021

Fig. 4.

Fig. 4.

A: Effects of MD and ketamine treatment on MPO activity in PFC and hippocampus of male and female Wistar rats. Values are expressed as mean ± E.P.M. * p < 0.05 vs. Control + Sal; #p < 0.05 vs. Deprived + Sal, according to one-way ANOVA followed by Tukey’s post-hoc test; &p<0.05 vs. sex and groups interaction according to two-way ANOVA. B: Effects of MD and ketamine treatment on IL-6 levels in PFC and hippocampus of male and female Wistar rats. Values are expressed as mean ± E.P.M. * p < 0.05 vs. Control + Sal; #p < 0.05 vs. Deprived + Sal, according to one-way ANOVA followed by Tukey’s post-hoc test; &p<0.05 vs. sex and groups interaction according to two-way ANOVA.